Emerging Technologies in Experimental Pharmacology: A Comprehensive Review of Novel Screening and Modeling Techniques

Experimental pharmacology plays a pivotal role in understanding drug actions, mechanisms, and safety profiles through laboratory-based investigations. Traditionally, it relied on in-vivo, in-vitro, and ex-vivo methods; however, these approaches often face limitations such as ethical concerns, lack of physiological relevance, and low predictive accuracy. Recent advancements have introduced innovative techniques that significantly enhance the precision, efficiency, and translational value of pharmacological studies. This review highlights cutting-edge methods such as in-silico modeling, high-throughput screening (HTS), 3D cell culture systems, and organ-on-a-chip technologies. In-silico techniques like molecular docking and QSAR modeling facilitate rapid prediction of drug-receptor interactions and biological activity, minimizing time and cost. HTS enables large-scale compound screening using automated platforms, accelerating early-stage drug discovery. 3D culture models and spheroid-based systems replicate the architectural and functional complexity of human tissues, offering improved insights into drug efficacy and resistance mechanisms. Additionally, organ-on-chip devices mimic organ-level physiology and allow real-time monitoring of drug effects, reducing dependence on animal models. These advancements not only address the limitations of conventional methods but also contribute to personalized medicine, toxicological screening, and disease modeling. The integration of these technologies into experimental pharmacology marks a transformative shift toward more predictive, ethical, and efficient drug development practices.